Cargando…
Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe
Human rabies vaccines have been shown to induce partial protection against members of phylogroup I bat lyssaviruses. Here, we investigated the capacity of a widely used rabies inactivated vaccine (Rabisin, Boehringer-Ingelheim) for veterinary use to cross-protect mice experimentally infected with Eu...
Autores principales: | Servat, Alexandre, Wasniewski, Marine, Cliquet, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832384/ https://www.ncbi.nlm.nih.gov/pubmed/31614675 http://dx.doi.org/10.3390/v11100936 |
Ejemplares similares
-
Potency of Veterinary Rabies Vaccines Marketed in Sri Lanka
por: Rathnadiwakara, Hasanthi, et al.
Publicado: (2023) -
Bat rabies surveillance in France: first report of unusual mortality among serotine bats
por: Picard-Meyer, Evelyne, et al.
Publicado: (2017) -
Molecular and serological survey of lyssaviruses in Croatian bat populations
por: Šimić, Ivana, et al.
Publicado: (2018) -
Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2021) -
Experimental infection of Foxes with European bat Lyssaviruses type-1 and 2
por: Cliquet, Florence, et al.
Publicado: (2009)